These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 18040886

  • 21. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.
    Liew FY, Millott S, Parkinson C, Palmer RM, Moncada S.
    J Immunol; 1990 Jun 15; 144(12):4794-7. PubMed ID: 2351828
    [Abstract] [Full Text] [Related]

  • 22. Th1/Th2-regulated arginase availability modulates Leishmania infection.
    Taylor-Robinson A.
    Trends Parasitol; 2001 Jun 15; 17(6):262. PubMed ID: 11378016
    [No Abstract] [Full Text] [Related]

  • 23. Boosting immunity to treat parasitic infections: Asaia bacteria expressing a protein from Wolbachia determine M1 macrophage activation and killing of Leishmania protozoans.
    Varotto-Boccazzi I, Epis S, Arnoldi I, Corbett Y, Gabrieli P, Paroni M, Nodari R, Basilico N, Sacchi L, Gramiccia M, Gradoni L, Tranquillo V, Bandi C.
    Pharmacol Res; 2020 Nov 15; 161():105288. PubMed ID: 33160070
    [Abstract] [Full Text] [Related]

  • 24. Leishmania amazonensis arginase compartmentalization in the glycosome is important for parasite infectivity.
    da Silva MF, Zampieri RA, Muxel SM, Beverley SM, Floeter-Winter LM.
    PLoS One; 2012 Nov 15; 7(3):e34022. PubMed ID: 22479507
    [Abstract] [Full Text] [Related]

  • 25. More than just protein building blocks: how amino acids and related metabolic pathways fuel macrophage polarization.
    Kieler M, Hofmann M, Schabbauer G.
    FEBS J; 2021 Jun 15; 288(12):3694-3714. PubMed ID: 33460504
    [Abstract] [Full Text] [Related]

  • 26. L-arginine availability and arginase activity: Characterization of amino acid permease 3 in Leishmania amazonensis.
    Aoki JI, Muxel SM, Zampieri RA, Acuña SM, Fernandes JCR, Vanderlinde RH, Sales MCOP, Floeter-Winter LM.
    PLoS Negl Trop Dis; 2017 Oct 15; 11(10):e0006025. PubMed ID: 29073150
    [Abstract] [Full Text] [Related]

  • 27. Metabolic characterization of Leishmania major infection in activated and nonactivated macrophages.
    Lamour SD, Choi BS, Keun HC, Müller I, Saric J.
    J Proteome Res; 2012 Aug 03; 11(8):4211-22. PubMed ID: 22724526
    [Abstract] [Full Text] [Related]

  • 28. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages.
    Iniesta V, Gómez-Nieto LC, Corraliza I.
    J Exp Med; 2001 Mar 19; 193(6):777-84. PubMed ID: 11257143
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
    Chakour R, Guler R, Bugnon M, Allenbach C, Garcia I, Mauël J, Louis J, Tacchini-Cottier F.
    Infect Immun; 2003 Sep 19; 71(9):5287-95. PubMed ID: 12933876
    [Abstract] [Full Text] [Related]

  • 31. Subversion of host cell signalling by the protozoan parasite Leishmania.
    Gregory DJ, Olivier M.
    Parasitology; 2005 Sep 19; 130 Suppl():S27-35. PubMed ID: 16281989
    [Abstract] [Full Text] [Related]

  • 32. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis.
    Evans TG, Thai L, Granger DL, Hibbs JB.
    J Immunol; 1993 Jul 15; 151(2):907-15. PubMed ID: 8335918
    [Abstract] [Full Text] [Related]

  • 33. New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.
    Vellozo NS, Rigoni TS, Lopes MF.
    Front Immunol; 2021 Jul 15; 12():704429. PubMed ID: 34249011
    [Abstract] [Full Text] [Related]

  • 34. An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis.
    Gaur U, Roberts SC, Dalvi RP, Corraliza I, Ullman B, Wilson ME.
    J Immunol; 2007 Dec 15; 179(12):8446-53. PubMed ID: 18056391
    [Abstract] [Full Text] [Related]

  • 35. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm.
    Alexander J, Bryson K.
    Immunol Lett; 2005 Jun 15; 99(1):17-23. PubMed ID: 15894106
    [Abstract] [Full Text] [Related]

  • 36. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E, Belkaid Y, Nguyen B, Wilson M, Sacks DL, Udey MC.
    J Invest Dermatol; 2002 Sep 15; 119(3):621-8. PubMed ID: 12230504
    [Abstract] [Full Text] [Related]

  • 37. Pleiotropic Effect of Hormone Insulin-Like Growth Factor-I in Immune Response and Pathogenesis in Leishmaniases.
    Reis LC, Ramos-Sanchez EM, Araujo FN, Leal AF, Ozaki CY, Sevillano OR, Uscata BA, Goto H.
    J Immunol Res; 2021 Sep 15; 2021():6614475. PubMed ID: 34036108
    [Abstract] [Full Text] [Related]

  • 38. Leishmania and the macrophage: a multifaceted interaction.
    Podinovskaia M, Descoteaux A.
    Future Microbiol; 2015 Sep 15; 10(1):111-29. PubMed ID: 25598341
    [Abstract] [Full Text] [Related]

  • 39. Cytokines and nitric oxide as effector molecules against parasitic infections.
    Liew FY, Wei XQ, Proudfoot L.
    Philos Trans R Soc Lond B Biol Sci; 1997 Sep 29; 352(1359):1311-5. PubMed ID: 9355122
    [Abstract] [Full Text] [Related]

  • 40. Regulation of macrophage subsets and cytokine production in leishmaniasis.
    Carneiro MB, Vaz LG, Afonso LCC, Horta MF, Vieira LQ.
    Cytokine; 2021 Nov 29; 147():155309. PubMed ID: 33334669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.